1. Singapore Stocks

  2. •

    Health services

  3. •

    Hospital/Nursing management
Q & M Dental Group (Singapore) Limited

Q & M Dental Group (Singapore) Limited

SSGX:QC7
0.52
SGD
-0.01
(-1.89%)
274.47MMarket Cap
Mar 01Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.09
0.12
0.13
0.16
0.13
0.13
0.14
0.15
0.22
0.19
0.19
0.19
0.21
- -
Basic EPS, GAAP
0.01
0.01
0.01
0.03
0.02
0.01
0.02
0.02
0.03
0.01
0.01
0.02
0.01
- -
Free Cash Flow per Basic Share
- -
-0.01
- -
0.01
0.01
0.01
0.02
0.02
0.04
0.02
0.03
0.03
0.03
- -
Dividend per Share
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.05
0.01
0.01
0.01
0.01
- -
Book Value per Share
0.06
0.08
0.1
0.12
0.12
0.12
0.13
0.13
0.1
0.1
0.1
0.11
0.11
0.1
Tangible Book Value per Share
0.05
0.04
0.02
0.04
0.06
0.06
0.07
0.07
0.04
0.04
0.04
0.06
0.02
0.04
Basic Weighted Avg Shares
832
858
936
953
956
949
943
944
944
941
946
947
947
942
Sales/Revenue/Turnover
71
100
124
155
123
121
128
138
206
181
183
181
197
- -
Operating Margin (%)
14.96
18.85
21.23
21.54
16.06
16.41
15.9
24.19
28.28
13.19
12.18
13.32
11.55
- -
Depreciation Expense
2
3
4
4
3
3
15
12
14
17
18
18
20
- -
Net Income, GAAP
6
9
11
28
24
14
18
20
30
11
12
14
9
- -
Effective Tax Rate (%)
6.95
10.78
11.88
6.2
3.03
5.12
9.65
11.32
15.64
16.96
18.96
11.73
18.6
- -
Profit Margin (%)
9.08
8.54
9.2
18.27
19.33
11.6
14.05
14.32
14.82
6.24
6.3
7.89
4.72
- -
Working Capital
31
41
62
44
-17
37
54
56
50
49
47
52
141
46
LT Debt
9
29
64
64
19
79
108
116
124
130
118
104
176
125
Total Equity
47
89
108
122
114
112
123
125
103
102
103
108
136
101
Return on Invested Capital (%)
23.56
18.95
15.92
23.95
15.91
9.89
11.74
11.38
20.86
6.32
6.55
7.02
5.31
- -
Return on Capital (%)
14.4
7.99
6.71
13.61
13.78
8.55
9.7
9.09
9.8
5.79
6.95
9.01
5.09
- -
Return on Common Equity (%)
17.25
13.96
13.51
27.37
20.98
12.54
15.46
16.21
27.84
11.64
11.78
13.93
8.86
- -

Capital Structure

SGD

•

in mil. unless spec.
Sep'22
Dec'22
Jun'23
ST Debt
11
11
11
LT Borrowings
85
85
83
LT Finance Leases
44
45
41
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
939
946
946
Market Capitalization
319
298
274

Working Capital

SGD

•

in mil. unless spec.
Sep'22
Dec'22
Jun'23
Total Current Assets
82
82
77
Cash, Cash Equivalents & STI
36
40
33
Accounts Receivable, Net
24
9
28
Inventories
18
11
12
Total Current Liabilities
30
33
31
Payables & Accruals
- -
- -
- -
ST Debt
11
11
11
Deferred Revenue
- -
- -
- -

Growth Rates

SGD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.89%
2.64%
25.62%
Free Cash Flow
-98.24%
29.21%
-0.2%
Net Income, GAAP
11.19%
-3.45%
-34.72%
Sales/Revenue/Turnover
6.24%
9.28%
9.16%
Total Cash Common Dividend
32.5%
8.38%
18.42%

Semi-annual Revenue

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
181
2025
- -
- -
197
2026
- -
- -
- -

Semi-annual Earnings Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.02
2025
- -
- -
0.01
2026
- -
- -
- -

Semi-annual Dividends Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.01
2025
- -
- -
0.01
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Chin Siau Ng
Full Time Employees
485
Sector
Health services
Industry
Hospital/Nursing management
Address
#05-01 IMM Building Singapore NE Singapore 609601
IPO Date
Nov 30, 2009
Website
qandm.com.sg
Similar Companies
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
Max Healthcare Institute Ltd (NSE:MAXHEALTH)
Fortis Healthcare Ltd. (NSE:FORTIS)
Bangkok Dusit Medical Services Public Co. Ltd. (SET:BDMS)
Yatharth Hospital and Trauma Care Services Limited (NSE:YATHARTH)
HCA Healthcare, Inc. (NYSE:HCA)
Business
Q & M Dental Group (Singapore) Limited is an investment holding company that operates as the largest private dental healthcare provider in Singapore, offering a comprehensive range of dental services through over 100 clinics island-wide, alongside operations in Malaysia, China and internationally. Founded in November 1996 and headquartered in Singapore, the company provides aesthetic and cosmetic dentistry, braces and orthodontics including Invisalign, CAD CAM digital dentistry, children dentistry, crowns and bridges, dentures, general dental treatment, gum disease treatment and surgery, dental implants, intraoral 3D scanning, jaw orthognathic surgery, nerve and root canal treatment, dental radiography and AI scans, wisdom tooth surgery, extractions, mouth and night guards, scaling and polishing, teeth grinding treatment, teeth whitening, tooth-coloured fillings, and services tailored for pregnant women; it also distributes dental equipment and supplies and operates a medical laboratory segment, supported by over 270 qualified dentists including about 40 specialists, and through its 49%-owned associate EM2AI offers AI-powered solutions such as EM2AIScan for X-ray analysis, EM2Clinic for treatment planning, and integrated dental management systems deployed across more than 150 clinics. The group serves over 600,000 patients annually across its primary healthcare, dental equipment distribution, and laboratory segments, with a focus on high-traffic urban and suburban areas in target markets including individual consumers, corporate clients via dental benefits and screenings, and dental professionals through training at Q & M College of Dentistry. In recent developments, the company wound down its medical laboratory business in September 2024 amid declining COVID-related demand, closed underperforming clinics as part of cost-cutting measures that drove FY24 profit after tax and minority interests up 27.1% to S$14.6 million despite a slight revenue dip, announced a share buyback of up to 50 million ordinary shares, expanded AI capabilities via EM2AI which secured regulatory approvals and an MoU with a regional provider to reach over 1,100 clinics, increased insider shareholdings including by CEO Dr. Ng Chin Siau, and in October 2025 entered a non-binding memorandum of understanding to acquire a stake in one of Thailand's largest private dental networks operating over 30 clinics primarily in Bangkok and northeastern provinces at an enterprise value of 1.95 billion baht, supported by profit guarantees from 2026 through 2033 and to be funded by cash and new shares.